Drug Profile
Research programme: cataract therapies - Senju
Alternative Names: Anti-cataracts - Senju; Calpain inhibitors research programme - Senju; Cataract therapies research programme - Senju; SJA 6017; SNJ 1757Latest Information Update: 05 Feb 2008
Price :
$50
*
At a glance
- Originator Senju Pharmaceutical
- Class Glycoproteins
- Mechanism of Action Calpain inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cataracts